Sarah Glover DO

Dr. Glover is currently the Division Chief and a Professor of Medicine in the Division of Gastroenterology at Tulane University in New Orleans, Louisiana. Dr Glover grew up in the Pacific Northwest, obtained a Bachelor of Arts in Chemistry at Seattle Pacific University and received her medical degree from Midwestern University in Chicago. Dr. Glover completed her Internal Medicine Residency and GI fellowship at the University of Illinois at Chicago before joining their faculty. She has also served as faculty at the University of Florida before being recruited to serve as the Division Chief for Digestive Diseases at her current institution in 2019. Dr. Glover's clinical expertise is in the medical management of complicated Crohn's Disease and ulcerative colitis, hereditary alpha tryptasemia, and short bowel syndrome. Over the past four years, she has focused her practice on improving care in individuals of African Ancestry with inflammatory bowel disease (IBD). Dr. Glover is an accomplished physician-scientist with a focus on innate immune mechanisms of gut inflammation and COVID-19 immune responses at mucosal surfaces. Her laboratory is currently funded with an NIH R01, a Chan Zuckerberg initiative grant, and funding from the Patient-Centered Outcomes Research Institute (PCORI). She also serves as Principle Investigator of multiple active IBD clinical trials. Dr. Glover is a Councilor of the Southern Society for Clinical Investigation, a Fellow of the American Gastroenterological Association. She is a member of the American College of Gastroenterology, American Osteopathic Association, Crohn's and Colitis Foundation, Federation of Clinical Immunology Societies, and the American Federation for Medical Research. She serves as Chair of the NIH's Small Business Innovation Research (SBIR) Digestive Sciences Emphasis Panel, as well as a reviewer for the American Gastroenterological Association Research Scholar Awards.